In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival

BACKGROUND: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment for patients with colorectal peritoneal metastases (CRPM). Patient selection is key to optimizing outcomes after CRS/HIPEC. The aim of this study was to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Ibrahim, Ubink, Inge, Ewalds, Roos S. G., Arkesteijn, Johanna G. T., Verheul, Henk M. W., de Wilt, Johannes H. W., Dekker, Helena M., Bremers, Andreas J. A., de Reuver, Philip R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246798/
https://www.ncbi.nlm.nih.gov/pubmed/35430666
http://dx.doi.org/10.1245/s10434-022-11718-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246798/
https://www.ncbi.nlm.nih.gov/pubmed/35430666
http://dx.doi.org/10.1245/s10434-022-11718-7

Ejemplares similares